|
|
.
NPI Detail
NPI: 1730132515
Type: Organization
Taxonomy Code: 282N00000X
Hospital-General
Hospitals/General Acute Care Hospital
750 XXXXXXXXXX XX
BOX 018
BOSTON, MA 021111526
Mailing and Business location phone:
(XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1730132515*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 36415
|
ROUTINE VENIPUNCTURE
|
XXXXX
|
$XXXXX
|
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXX.XX
|
| 82565
|
ASSAY OF CREATININE
|
XXXXX
|
$XXXXX.XX
|
| 84520
|
ASSAY OF UREA NITROGEN
|
XXXXX
|
$XXXXX.XX
|
| 80051
|
ELECTROLYTE PANEL
|
XXXXX
|
$XXXXX.XX
|
| 82947
|
ASSAY GLUCOSE BLOOD QUANT
|
XXXXX
|
$XXXXX.XX
|
| 82310
|
ASSAY OF CALCIUM
|
XXXXX
|
$XXXXX.XX
|
| 84460
|
ALANINE AMINO (ALT) (SGPT)
|
XXXXX
|
$XXXX.XX
|
| 84450
|
TRANSFERASE (AST) (SGOT)
|
XXXXX
|
$XXXX.XX
|
| 83735
|
ASSAY OF MAGNESIUM
|
XXXXX
|
$XXXXX.XX
|
| 84100
|
ASSAY OF PHOSPHORUS
|
XXXX
|
$XXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J9271
|
Inj pembrolizumab
|
XXXXX
|
$XXXXXXX.XX
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXX
|
$XXXXXXX.XX
|
| J1453
|
Fosaprepitant injection
|
XXXXX
|
$XXXXX.XX
|
| J0485
|
Belatacept injection
|
XXXXX
|
$XXXXXX.XX
|
| J3262
|
Tocilizumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXX
|
$XXXXX.XX
|
| J1439
|
Inj ferric carboxymaltos 1mg
|
XXXXX
|
$XXXXX.XX
|
| J9299
|
Injection, nivolumab
|
XXXXX
|
$XXXXXX.XX
|
| J0878
|
Daptomycin injection
|
XXXXX
|
-
|
| J9267
|
Paclitaxel injection
|
XXXXX
|
-
|
| J1756
|
Iron sucrose injection
|
XXXXX
|
-
|
| J0585
|
Injection,onabotulinumtoxina
|
XXXXX
|
$XXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXX
|
-
|
| J3380
|
Injection, vedolizumab
|
XXXXX
|
$XXXXXX.XX
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J9176
|
Injection, elotuzumab, 1mg
|
XXXXX
|
$XXXXX.XX
|
| J1569
|
Gammagard liquid injection
|
XXXXX
|
$XXXXXX.XX
|
| J0896
|
Inj luspatercept-aamt 0.25mg
|
XXXXX
|
$XXXXXX.XX
|
| J0222
|
Inj., patisiran, 0.1 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXX
|
$XXXXXX.XX
|
| J0717
|
Certolizumab pegol inj 1mg
|
XXXXX
|
$XXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXXX
|
$XXXXXXX.XX
|
| G0378
|
Hospital observation per hr
|
XXXX
|
-
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
